“…PEMFs have been successfully tested with numerous in vitro models of osteoblastic phenotype, most noticeably rat calvaria osteoblasts [Bodamyali et al, ; Li et al, ; Kuan‐Jung Li et al, ; Selvamurugan et al, ; Hopper et al, ; Zhang et al, ; Zhou et al, ; Yan et al, ; Xie et al, ; Wang et al, ] and human bone marrow stromal cells [Sun et al, , ; Tsai et al, ; Jansen et al, ; Esposito et al, ; Ceccarelli et al, ; Fu et al, ; Kaivosoja et al, ; Petecchia et al, ; Selvamurugan et al, ; He et al, ] although primary human osteoblasts from other sources, for example, femur [Barnaba et al, ; Ehnert et al, , , ] are also well accounted for in the literature. A considerable amount of evidence has also been collected using osteoblastic cell lines, both of human origin, for example, SaOS‐2 [Hannay et al, ; Martino et al, ; Borsje et al, ; Kaivosoja et al, ] or MG‐63 [De Mattei et al, , ; Lohmann et al, ; Sollazzo et al, ; Noriega‐Luna et al, ], or of murine origin, for example, MC3T3 [Diniz et al, , ; Patterson et al, ; Sakai et al, ; Soda et al, ; Li et al, ; Lin et al, ; Zhai et al, ; Tong et al, ] or MLO‐Y4 [Lohmann et al, ; Wang et al, ]. Various cell models appear to require slightly different stimulation parameters, depending on cell type, maturation stage, or culture conditions; thus, when planning a new study, exposure conditions should be varied appropriately and it does not appear to be possible to set universally valid parameters even for osteoblast studies.…”